Mitigating Risk: Key Considerations for Facility Owners in Pharmaceutical Manufacturing

Ensuring the reliability of cleanroom environments with performance coatings.

A Medical device manufacturing facility.
A Medical device manufacturing facility.
Sherwin-Williams

Pharmaceutical manufacturing operates at the intersection of strict regulatory compliance and groundbreaking innovation. Facility owners face unique challenges in ensuring their operations run smoothly while adhering to stringent standards. One critical aspect that often goes unnoticed is the role of high-performance coatings in mitigating risks and ensuring the reliability of cleanroom environments.

Ensuring Regulatory Compliance and Standards

Pharmaceutical manufacturers must adhere to FDA guidelines and Current Good Manufacturing Practices (cGMP) to ensure product quality and consumer safety. Non-compliance can lead to product recalls and financial repercussions, making it essential for facility owners to prioritize surfaces that meet these standards. High-performance coatings are specifically engineered to address these challenges by:

  • Creating Smooth, Non-Porous Surfaces: These coatings prevent microbial growth by eliminating gaps where contaminants could hide.
  • Withstanding Harsh Cleaning Protocols: High-performance coatings endure repeated exposure to aggressive disinfectants, sterilants and other cleaning chemicals without deteriorating.

Managing Global Supply Chain Risks

The BIOSECURE Act limits sourcing from foreign "companies of concern," which may slow drug production and shift to domestic sourcing. This increases scrutiny of companies relying on foreign CDMOs (Contract Development and Manufacturing Organizations). Facility owners must navigate these risks by ensuring their surfaces are compliant with domestic standards. High-performance coatings offer:

  • Durability and Sterility: These coatings maintain structural integrity under extreme conditions, supporting sterile operations.
  • Eco-Friendly Solutions: Water-based, low-VOC formulations align with environmental responsibility and LEED compliance for CAPEX projects.

Controlling Expenses and Protecting Revenue

Downtime in pharmaceutical manufacturing can cost millions a day, impacting both reputation and bottom line. High-performance coatings are designed to enhance operational efficiency and minimize disruptions by:

  • Enabling Quick Turnaround: Coatings with rapid cure times allow for faster installation and maintenance, reducing facility downtime during repairs or shutdowns.
  • Delivering Durability: Engineered to withstand heavy foot traffic, machinery and repeated chemical exposure, these coatings reduce the need for frequent repairs or replacements.

Comprehensive Solutions for Cleanroom Design

Cleanrooms present unique challenges that require precision-engineered solutions. High-performance coatings meet these demands through features tailored to the specific needs of pharmaceutical environments:

  • Seamless Flooring Systems: These systems eliminate cracks, seams and joints where contaminants could collect, ensuring a hygienic and sterile environment.
  • Chemical-Resistant Wall Coatings: Walls and ceilings coated with protective finishes resist stains, abrasions and harsh cleaning agents, maintaining their integrity over time.
  • Static Control Options: In facilities where static electricity could pose a safety or contamination risk (like medical device manufacturing), specialized coatings dissipate static charges, contributing to both safety and product quality.
  • Intumescent Fireproofing: Offers distinct advantages over cementitious fireproofing for the cleanroom environment.
    • Aesthetic Appeal: Intumescent coatings are applied in thin, smooth layers, making them more visually appealing and suitable for environments where cleanliness and appearance are critical.
    • Durability: Intumescent coatings are less prone to cracking, flaking or dusting, which can be problematic in cleanrooms where maintaining a contaminant-free environment is essential.
    • Clean Application: The application process for intumescent coatings is cleaner and quicker compared to cementitious coatings, reducing the risk of contamination in cleanrooms.
    • Contamination Risk: Cementitious coatings can deteriorate over time, leading to cracking, flaking or dusting, which can introduce contaminants into cleanrooms. 

The Future of Coatings in Pharmaceutical Manufacturing

As pharmaceutical manufacturing evolves, the role of coatings continues to expand. Emerging technologies offer new ways to reduce contamination risks and extend maintenance cycles.

High-performance coatings are far more than just a finishing touch – they are a foundational component of pharmaceutical manufacturing facility design. By enabling sterility, durability and compliance, they empower manufacturers to deliver life-saving products with confidence.

Michael C. Durbin is the Market Segment Manager of Pharmaceutical and Biosciences, North America, Sherwin-Williams Protective & Marine Coatings.

More in Medical